Differential Expression of Androgen Receptor in Type I and Type II Endometrial Carcinomas: A Clinicopathological Analysis and Correlation with Outcome.

Abu Shahin, Nisreen; Aladily, Tariq; Abu Alhaj, Nezeen; Al-Khader, Ali; Alqaqa, Shefa; Aljaberi, Reyad; Amer, Lama; Elshebli, Sanad

Abu Shahin, Nisreen; Aladily, Tariq; Abu Alhaj, Nezeen; Al-Khader, Ali; Alqaqa, Shefa; Aljaberi, Reyad; Amer, Lama; Elshebli, Sanad.

Afiliación

Abu Shahin N; Department of Pathology, Faculty of Medicine, University of Jordan, Amman, Jordan.
Aladily T; Department of Pathology, Faculty of Medicine, University of Jordan, Amman, Jordan.
Abu Alhaj N; Department of Pathology, Faculty of Medicine, University of Jordan, Amman, Jordan.
Al-Khader A; Department of Pathology, Faculty of Medicine, Al-Balqa Applied University, Salt, Jordan.
Alqaqa S; Department of Pathology, Faculty of Medicine, Al-Balqa Applied University, Salt, Jordan.
Aljaberi R; Faculty of Medicine,University of Jordan, Amman, Jordan.
Amer L; Faculty of Medicine,University of Jordan, Amman, Jordan.
Elshebli S; Faculty of Medicine,University of Jordan, Amman, Jordan.

Oman Med J ; 36(2): e245, 2021 Mar.

Article en En | MEDLINE | ID: mdl-33833869

Palabras clave

Adenocarcinoma, Clear Cell; Androgen Receptor; Carcinoma, Endometrioid; Cystadenocarcinoma, Serous; Endometrial Cancer

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Tipo de estudio: Prognostic_studies Idioma: En Revista: Oman Med J Año: 2021 Tipo del documento: Article País de afiliación: Jordania Pais de publicación: Omán

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google